32.98

0.43% 0.13

Tandem Diabetes Care Inc (TNDM)

Overview News Price History Option Chain Financials Why TNDM Down? Discussions Forecast Stock Split

Tandem Diabetes Care Inc stock is traded at $32.98, with a volume of 535.25K. It is up +0.43% in the last 24 hours and down -21.04% over the past month. Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on a tubeless pump. Nearly three-quarters of total revenue is derived from the us, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days.

Previous Close:

$32.85

Open:

$32.72

24h Volume:

535.25K

Relative Volume:

0.45

Market Cap:

$2.15B

Revenue:

$796.00M

Net Income/Loss:

$-136.49M

P/E Ratio:

-10.21

EPS:

-3.23

Net Cash Flow:

$-64.24M

1W Performance:

+0.18%

1M Performance:

-21.04%

6M Performance:

-26.23%

1Y Performance:

+109.46%

1-Day Range:

$32.66

$33.88

1-Week Range:

$31.10

$33.88

52-Week Range:

$13.82

$53.69

Tandem Diabetes Care Inc Stock (TNDM) Company Profile

Name

Tandem Diabetes Care Inc

Sector

Healthcare (1181)

Industry

Medical Devices (155)

Phone

858-366-6900

Address

12400 HIGH BLUFF DRIVE, San Diego, CA

Employee

2,400

Twitter

@tandemdiabetes

Next Earnings Date

2024-11-06

Latest SEC Filings

TNDM's Discussions on Twitter

Tandem Diabetes Care Inc Stock (TNDM) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-04-23	Downgrade	Citigroup	Buy → Neutral
May-05-23	Downgrade	BofA Securities	Neutral → Underperform
Apr-24-23	Downgrade	Raymond James	Outperform → Mkt Perform
Mar-29-23	Initiated	UBS	Neutral
Jan-26-23	Initiated	Wolfe Research	Peer Perform
Nov-15-22	Upgrade	Wells Fargo	Underweight → Equal Weight
Oct-18-22	Initiated	Barclays	Overweight
Oct-12-22	Initiated	Jefferies	Buy
Aug-09-22	Downgrade	Wells Fargo	Overweight → Underweight
Mar-02-22	Resumed	BofA Securities	Neutral
Jan-19-22	Upgrade	Wells Fargo	Equal Weight → Overweight
Jul-21-21	Resumed	Cowen	Outperform
May-25-21	Initiated	Barclays	Underweight
Dec-15-20	Downgrade	Wells Fargo	Overweight → Equal Weight
Aug-20-20	Initiated	Wells Fargo	Overweight
Jul-31-20	Upgrade	Guggenheim	Neutral → Buy
Jul-06-20	Upgrade	Citigroup	Neutral → Buy
Jun-18-20	Reiterated	Raymond James	Outperform
Apr-24-20	Downgrade	SVB Leerink	Outperform → Mkt Perform
Mar-23-20	Downgrade	Guggenheim	Buy → Neutral
Mar-05-20	Initiated	Citigroup	Neutral
Feb-06-20	Initiated	Raymond James	Outperform
Feb-04-20	Downgrade	Robert W. Baird	Outperform → Neutral
Oct-18-19	Initiated	Guggenheim	Buy
Oct-04-19	Upgrade	UBS	Neutral → Buy
May-17-19	Reiterated	BofA/Merrill	Neutral
May-13-19	Initiated	SVB Leerink	Outperform
Mar-08-19	Initiated	BMO Capital Markets	Outperform
Mar-05-19	Reiterated	BofA/Merrill	Neutral
Feb-27-19	Reiterated	Lake Street	Buy
Nov-21-18	Upgrade	Robert W. Baird	Neutral → Outperform
Sep-26-18	Reiterated	Dougherty & Company	Buy
Sep-26-18	Reiterated	Piper Jaffray	Overweight

View All

Tandem Diabetes Care Inc Stock (TNDM) Latest News

Nov 03, 2024

Analysts Estimate Tandem Diabetes Care, Inc. (TNDM) to Report a Decline in Earnings: What to Look Out for - MSN

Nov 03, 2024

abrdn plc Makes New Investment in Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - MarketBeat

Nov 03, 2024

Nov 01, 2024

Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Shares Bought by Stephens Investment Management Group LLC - MarketBeat

Nov 01, 2024

Oct 31, 2024

Mirae Asset Global Investments Co. Ltd. Boosts Stock Position in Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - MarketBeat

Oct 31, 2024

Tandem Diabetes Care Announces Upcoming Conference Participation - BioSpace

Oct 31, 2024

Oct 30, 2024

Tandem Diabetes Care (TNDM) Set to Announce Earnings on Wednesday - MarketBeat

Oct 30, 2024

Oct 27, 2024

Assenagon Asset Management S.A. Acquires 66,138 Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM) - MarketBeat

Oct 27, 2024

Oct 25, 2024

Apple Tests Blood-Sugar App in Sign of Its Health Ambitions - BNN Bloomberg

Oct 25, 2024

Recent 8.8% pullback isn't enough to hurt long-term Tandem Diabetes Care (NASDAQ:TNDM) shareholders, they're still up 77% over 1 year - Simply Wall St

Oct 25, 2024

Oct 24, 2024

(TNDM) Trading Signals - Stock Traders Daily

Oct 24, 2024

Tandem Diabetes Care's SWOT analysis: insulin pump maker faces growth hurdles - Investing.com India

Oct 24, 2024

Tandem Diabetes Care's SWOT analysis: insulin pump maker faces growth hurdles By Investing.com - Investing.com South Africa

Oct 24, 2024

Further weakness as Tandem Diabetes Care (NASDAQ:TNDM) drops 14% this week, taking three-year losses to 75% - Yahoo Finance

Oct 24, 2024

Oct 21, 2024

Down -21.69% in 4 Weeks, Here's Why Tandem Diabetes Care (TNDM) Looks Ripe for a Turnaround - MSN

Oct 21, 2024